Stroke and Its Modification in Parkinson's Disease
Stroke 21:1395-1399, Struck,L.K.,et al, 1990
Movement Disorders in Alcoholism:A Review
Neurol 40:741-746, Neiman,J.,et al, 1990
Ataxic Sensory Neuropathy and Dorsal Root Ganglionitis Associated with Sjogren's Syndrome
Ann Neurol 27:304-315, Griffin,J.W.,et al, 1990
Clinicopath Conf
Familial Visceral Myopathy (Oculogastrointestinal Muscular Dystrophy) , Case 12-1990, NEJM 322:829-8, 1, 19, 1990
Mortality Associated with Early and Late Levodopa Therapy Initiation in Parkinson's Disease
Neurol 40:265-269, Scigliano,G.,et al, 1990
Dopa-Responsive Dystonia:The Spectrum of Clinical Manifestations in a Large North American Family
Neurol 40:66-69, Nygaard,T.G.,et al, 1990
Subcutaneous Apomorphine in the Treatment of Parkinson's Disease
JNNP 53:96-101, Frankel,J.P.,et al, 1990
A Large Kindred with Autosomal Dominant Parkinson's Disease
Ann Neurol 27:276-282, Golbe,L.I.,et al, 1990
The Changing Patterns of Death Rates in Parkinsonism
Neurol 40:42-49, Kurtzke,J.F.&Murphy,F.M., 1990
Extrapyramidal Involvement in Rett's Syndrome
Neurol 40:293-295, FitzGerald,P.M.,et al, 1990
A Comparison of Effects of Controlled-Release Levodopa (Madopar CR) with Levodopa in Late Parkinson's Disease
JNNP 53:220-223, MacMahon,D.G.,et al, 1990
PET Study in Progressive Supranuclear Palsy, Hypometabolic Pattern
Arch Neurol 47:747-752, Blin,J.,et al, 1990
Cortical-Basal Ganglionic Degeneration
Neurol 40:1203-1212, Riley,D.E.,et al, 1990
Striatonigral Degeneration:Clinical, MRI, & Pathologic Correlation
Neurol 40:710-711, O'Brien,C.,et al, 1990
Geriatrics:Gait Disorders in the Elderly
NEJM 322:1441-1446, Sudarsky,L., 1990
'Rubral'Gait Ataxia
Neurol 40:1004-1005, Felice,K.J.,et al, 1990
Progressive Rubella Panencephalitis
In Handbk of Clin Neurol, Vinken & Bruyn, Ed, N Holland Publ Co, 56:405-416, Wolinsky,J.S., 1990
Sustained Enteral Administration of Levodopa Increases and Interrupted Infusion Decreases Levodopa Dose Requirements
Neurol 40:995-997, Cedarbaum,J.M.,et al, 1990
Apomorphine Test to Predict Dopaminergic Responsiveness in Parkinsonian Syndromes
Lancet 336:32-34, Hughes,A.J.,et al, 1990
Two Decades of Increasing Mortality from Parkinson's Disease Among the US Elderly
Arch Neurol 47:731-734, Lilienfeld,D.E.,et al, 1990
Environmental Risk Factors in Parkinson's Disease
Neurol 40:1218-1221, Koller,W.,et al, 1990
Pyramid Sale in the Bucket Shop:DATATOP Bottoms Out
Neurol 40:1337-1339, Landau,W.M., 1990
Parkinsonism Due to a Basal Ganglia Lacunar State:Clinicopathologic Correlation
Neurol 40:897-900, Murrow,R.W.,et al, 1990
Cell Implantation in Parkinson's Disease
BMJ 301:301-302, Williams,A., 1990
Transplantation of Human Fetal Dopamine Cells for Parkinson's Disease
Arch Neurol 47:505-512, Freed,C.R.,et al, 1990
Parkinson's Disease, Review Article
Lancet 335:948-952, Marsden,C.D., 1990
Magnetic Resonance Imaging in Parkinson's Disease
Arch Neurol 47:735-737, Huber,S.J.,et al, 1990
Clozapine in the Treatment of Parkinsonian Patients with Dopaminomimetic Psychosis
Neurol 40:832-834, Wolters,E.Ch.,et al, 1990
Decreased Efficacy of Levodopa with Carbidopa in Parkinsonian Patients after Adrenal-to-Caudate Implants
Neurol 40:845-846, Tsui,J.K.C.,et al, 1990
Parkinson's Disease and Driving Ability
JNNP 53:580-582, Madeley,P.,et al, 1990
Hypoxic-Ischemic Damage of the Basal Ganglia
Mov Disord 5:219-224, Hawker, K. & Lang, A.E., 1990
Selegiline Use to Prevent Progression of Parkinson's Disease
Arch Neurol 46:1275-1279, Elizan,T.S.,et al, 1989
Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease
The Parkinson Study Group, NEJM 321:1364-13711989., , 1989
DATATOP:A Multicenter Controlled Clinical Trial in Early Parkinson's Disease
Parkinson Study Group, Arch Neurol 46:1052-10601989., , 1989
Selegiline as an Adjunct to Conventional Levodopa Therapy in Parkinson's Disease
Arch Neurol 46:1280-1283, Elizan,T.S.,et al, 1989
Swallowing Abnormalities and Their Response to Treatment in Parkinson's Disease
Neurol 39:1309-1314, Bushman,M.,et al, 1989
Variables Predicting Surgical Outcome in Symptomatic Hydrocephalus in the Elderly
Neurol 39:1601-1604, Graff-Radford,R.N.,et al, 1989
Symptomatic Congenital Hydrocephalus in the Elderly Simulating Normal Pressure Hydrocephalus
Neurol 39:1596-1600, Graff-Radford,N.R.&Godersky,J.C., 1989
Dose-Dependent Memory Impairment in Parkinson's Disease
Neurol 39:438-440, Huber,S.J.,et al, 1989
Clinicopath Conf
Subacute Cerebellar Degeneration, Cystadenocarcinoma of Ovary, (with Paraneoplastic Syndrome) , Case, 34-1EJM 321:524-535,1989., 1989
Adrenoleukodystrophy
JAMA 262:1504-1506, Ladenson,P.W., 1989
Clinicopath Conf
Chronic Osteomyelitis of Spine, with Intervertebral Diskitis (T3-T4) & Epidural Abscess (Staph Aureu, ) , Cas9,NEJM 320:1610-1618,1989., 1989
Cerebellopontine Angle Epidermoid Cysts:A Report on 30 Cases
JNNP 52:986-990, deSouza,C.E.,et al, 1989
Pergolide and Selegiline for Parkinson's Disease
The Medical Letter, 31:81-841989., , 1989
Continuous Levodopa Infusions to Treat Complex Dystonia in Parkinson's Disease
Neurol 39:888-891, Sage,J.I.,et al, 1989
Dopa Responsive Dystonia:A Treatable Condition Misdiagnosed as Cerebral Palsy
BMJ 298:1019-1020, Boyd,K.&Patterson,V., 1989
Cognitive Impairments Associated with Early Parkinson's Disease
Neurol 39:557-561, Levin,B.E.,et al, 1989
Clinical and Pathological Aspects of Parkinsonism in Alzheimer's Disease, A Role for Extranigral Factors?
Arch Neurol 46:651-657, Morris,J.C.,et al, 1989
Neuropathological Distinction Between Parkinson's Dementia and Parkinson's Plus Alzheimer's Disease
Ann Neurol 26:309-320, delaMonte,S.M.,et al, 1989
Environmental Factors and Parkinson's Disease:A Case-Control Study in China
Neurol 39:660-664, Tanner,C.M.,et al, 1989